Literature DB >> 2408804

Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro.

E Carlsen, A C Mallet, H Prydz.   

Abstract

Monocytes and macrophages synthesize thromboplastin when induced by a number of compounds. Our experiments show that cyclosporine A (CyA) enhances the synthesis of procoagulant activity in monocytes and in whole mononuclear cells (MNC) about two-fold when phytohaemagglutinin (PHA) is the stimulant. The enhancement is inhibited by actinomycin D and cycloheximide. CyA alone had no effect, but in the presence of PHA or phorbol ester CyA induces or enhances the synthesis of a vitamin K-dependent procoagulant in the MNC cultures. This procoagulant acts synergistically with thromboplastin synthesized in the same cultures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408804      PMCID: PMC1577035     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation.

Authors:  H J Helin; T S Edgington
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 2.  The role of cellular cooperation in thromboplastin synthesis.

Authors:  T Lyberg; H Prydz
Journal:  Nouv Rev Fr Hematol       Date:  1983

3.  Increased tissue factor activity of monocytes/macrophages isolated from canine renal allografts.

Authors:  H Rothberger; M Barringer; J Meredith
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

4.  The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator.

Authors:  J W Shands
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

5.  Is lymphocyte co-operation necessary for thromboplastin synthesis by human monocytes?

Authors:  T Lyberg; H Prydz
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

6.  Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages.

Authors:  U Lindahl; S O Kolset; J Bøgwald; B Osterud; R Seljelid
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

7.  Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse.

Authors:  C L Geczy; E Farram; D K Moon; P A Meyer; I F McKenzie
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

8.  Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

Authors:  A W Thomson; D K Moon; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

9.  Human monocytes have prothrombin cleaving activity.

Authors:  N Hogg
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR.

Authors:  H Helin; T S Edgington
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 3.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Allogenic induction of thromboplastin synthesis in monocytes and endothelial cells. Biphasic effect of cyclosporin A.

Authors:  E Carlsen; G Gaudernack; C Filion-Myklebust; K S Pettersen; H Prydz
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Differential effect of alpha-interferon and gamma-interferon on thromboplastin response in monocytes and endothelial cells.

Authors:  E Carlsen; M B Stinessen; H Prydz
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

6.  Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.

Authors:  R A Olivo; N G Nascimento; C F P Teixeira; P F Silveira
Journal:  Clin Dev Immunol       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.